Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025.
Filed with BSE · · 12 pages · English
On 6ix: 6ix.com/news/unaudited-financial-results-for-the-quarter-and-half-year-ended-september-30-2025-2
1. Submission of Unaudited Standalone Financial Results along with Auditors’ Report for the quarter and half year ended 30th September, 2025: ended 30 th September, 2025: The Financial Results are also available on the website of the Company at www.venmaxdrugs.com and on the website of BSE www.bseindia.com. 2. Other Matters Considered: 2. Other Matters Considered: In continuation of the proposal f
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Board Meeting Outcome for Outcome Of The Board Meeting
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 05 2025
- Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended September 30, 2025.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Oct 14 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Later from Venmax Drugs & Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 14 2025
- Announcement under Regulation 30 (LODR)-Resignation of Director
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 24 2025
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 25 2025
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals